批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2018/04/05 |
SUPPL-35(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/07/13 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/10/28 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2015/12/23 |
SUPPL-29(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/01/15 |
SUPPL-27(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/07/11 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2011/12/23 |
SUPPL-24(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/06/25 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/04/30 |
SUPPL-20(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2010/03/02 |
SUPPL-16(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2010/03/02 |
SUPPL-15(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2009/07/07 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/08/07 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/04/11 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/06/26 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/12/28 |
SUPPL-12(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2004/10/29 |
SUPPL-11(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2003/02/26 |
SUPPL-5(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2003/01/17 |
SUPPL-8(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2002/01/10 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/02/05 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/01/10 |
SUPPL-6(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2000/05/23 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/04/22 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/03/17 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/07/25 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
001 |
4978672 |
2011/06/03 |
|
|
U-203 |
|
|
PDF格式 | **本条是由Drugfuture回溯的历史信息** |
与本品治疗等效的药品
活性成分:LETROZOLE 剂型/给药途径:TABLET;ORAL 规格:2.5MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020726 |
001 |
NDA |
FEMARA |
LETROZOLE |
TABLET;ORAL |
2.5MG |
Prescription |
Yes |
Yes |
AB |
1997/07/25
|
NOVARTIS PHARMS |
090289 |
001 |
ANDA |
LETROZOLE |
LETROZOLE |
TABLET;ORAL |
2.5MG |
Prescription |
No |
No |
AB |
2011/06/03
|
TEVA PHARMS |
090934 |
001 |
ANDA |
LETROZOLE |
LETROZOLE |
TABLET;ORAL |
2.5MG |
Prescription |
No |
No |
AB |
2011/06/03
|
ACCORD HLTHCARE |
091191 |
001 |
ANDA |
LETROZOLE |
LETROZOLE |
TABLET;ORAL |
2.5MG |
Prescription |
No |
No |
AB |
2011/06/03
|
RYAN LABS |
200161 |
001 |
ANDA |
LETROZOLE |
LETROZOLE |
TABLET;ORAL |
2.5MG |
Prescription |
No |
No |
AB |
2011/06/03
|
NATCO PHARMA LTD |
201804 |
001 |
ANDA |
LETROZOLE |
LETROZOLE |
TABLET;ORAL |
2.5MG |
Discontinued |
No |
No |
AB |
2011/06/03
|
INDICUS PHARMA |
205869 |
001 |
ANDA |
LETROZOLE |
LETROZOLE |
TABLET;ORAL |
2.5MG |
Prescription |
No |
No |
AB |
2018/11/14
|
BEIJING YILING |
211717 |
001 |
ANDA |
LETROZOLE |
LETROZOLE |
TABLET;ORAL |
2.5MG |
Prescription |
No |
No |
AB |
2019/01/11
|
EUGIA PHARMA |